Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 25,224 | 20,119 | 17,363 | 15,193 | 15,318 |
| Gross Profit | 25,224 | 20,119 | 17,363 | 15,193 | 15,318 |
| Operating Expenses | 10,662 | 9,987 | 9,845 | 10,479 | 10,841 |
| Operating Income | 14,562 | 10,132 | 7,518 | 4,714 | 4,477 |
| Interest Expense | 2,016 | 1,442 | 963 | 857 | 967 |
| Other Income | -12 | 1 | 88 | 32 | 2 |
| Pre-tax Income | 12,534 | 8,691 | 6,643 | 3,889 | 3,512 |
| Income Tax | 2,267 | -519 | 967 | 840 | 438 |
| Net Income Continuous | 10,267 | 9,210 | 5,676 | 3,049 | 3,074 |
| Minority Interests | -230 | 49 | N/A | N/A | N/A |
| Net Income | $10,497 | $9,161 | $5,676 | $3,049 | $3,074 |
| EPS Basic Total Ops | 0.58 | 0.51 | 0.32 | 0.17 | 0.17 |
| EPS Basic Continuous Ops | 0.57 | 0.51 | 0.32 | 0.17 | 0.17 |
| EPS Diluted Total Ops | 0.58 | 0.50 | 0.31 | 0.17 | 0.17 |
| EPS Diluted Continuous Ops | 0.56 | 0.51 | 0.31 | 0.17 | 0.17 |
| EBITDA(a) | $21,924 | $16,128 | $12,505 | $9,451 | $9,391 |